Surgery for Diabetic Eye Complications (Q36128850)

12 August 2017

Surgery for Diabetic Eye Complications (English)

1 reference

12 August 2017

María H Berrocal

1

1 reference

PubMed ID

27612846

12 August 2017

Luis A Acaba

series ordinal

2

1 reference

PubMed ID

27612846

12 August 2017

Alexandra Acaba

series ordinal

3

1 reference

12 August 2017

1 October 2016

1 reference

12 August 2017

Current diabetes report

1 reference

12 August 2017

16

1 reference

12 August 2017

99

1 reference

12 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-016-0787-6

12 August 2017

0 references

cites work

A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Transconjunctival sutureless 23-gauge vitrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

HEADS-UP SURGERY FOR VITREORETINAL PROCEDURES: An Experimental and Clinical Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

ULTRA-WIDEFIELD FUNDUS IMAGING: A Review of Clinical Applications and Future Trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

INTRASURGICAL MICROSCOPE-INTEGRATED SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY-ASSISTED MEMBRANE PEELING.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Combined rhegmatogenous and traction retinal detachment in proliferative diabetic retinopathy: clinical manifestations and surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Staining ability and biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Incidence of cataract extraction after diabetic vitrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0787-6

Vitreous contraction in proliferative diabetic retinopathy

21 January 2018

1 reference

12 December 2020

Vitrectomy for Diabetic Traction Retinal Detachment Involving the Macula

1 reference

12 December 2020

Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy

1 reference

12 December 2020

Vitrectomy for Diabetic Vitreous Hemorrhage

1 reference

12 December 2020

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group

1 reference

12 December 2020

Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series

1 reference

12 December 2020

Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5

1 reference

12 December 2020

Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group

1 reference

12 December 2020

Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator

1 reference

12 December 2020

The Effect of Lensectomy on the Incidence of Iris Neovascularization and Neovascular Glaucoma After Vitrectomy for Diabetic Retinopathy

1 reference

12 December 2020

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Grou

1 reference

12 December 2020

Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction

1 reference

12 December 2020

Triple therapy: Phaco-vitrectomy with ILM peeling, retinal endophotocoagulation, and intraoperative use of bevacizumab for diffuse diabetic macular edema.

1 reference

12 December 2020

Retinal detachment after bevacizumab

1 reference

12 December 2020

Diabetic traction retinal detachment. Factors influencing final visual acuity

1 reference

12 December 2020

Vitrectomy for diabetic rhegmatogenous retinal detachment

1 reference

12 December 2020

10.1007/S11892-016-0787-6

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

27612846